公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now? | Zuckermann A.; SHOEI-SHEN WANG ; Epailly E.; Barten M.J.; Sigurdardottir V.; Segovia J.; Varnous S.; Turazza F.M.; Potena L.; Lehmkuhl H.B. | Transplantation Reviews | 27 | 26 | |
2013 | Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation | Kobashigawa J.; Ross H.; Bara C.; Delgado J.F.; Dengler T.; Lehmkuhl H.B.; SHOEI-SHEN WANG ; Dong G.; Witte S.; Junge G.; Potena L. | Transplant Infectious Disease | 49 | 47 | |
2013 | Everolimus versus mycophenolate mofetil in heart transplantation: A randomized, multicenter trial | Eisen H.J.; Kobashigawa J.; Starling R.C.; Pauly D.F.; Kfoury A.; Ross H.; SHOEI-SHEN WANG ; Cantin B.; Van Bakel A.; Ewald G.; Hirt S.; Lehmkuhl H.; Keogh A.; Rinaldi M.; Potena L.; Zuckermann A.; Dong G.; Cornu-Artis C.; Lopez P. | American Journal of Transplantation | 171 | 159 |